Pharmapac (u.k.) Limited

Pharmapac (U.K.) Limited, based in Wirral, UK, is a large, active company established 28 years ago. Employing 133 people, it boasts assets of £7,084,921 and a yearly revenue of £12,152,483. With a real address and two directors, the company operates in the manufacture of basic pharmaceutical products. A Google rating of 1.0 from one review suggests room for improvement. It's a regular importer of plastics and plastic products, with 76 months of import activity, and has exported none for four months.

The company’s website highlights its role as a trusted contract manufacturer with an MHRA license, offering services like manufacturing, filling, packing, and project management. It caters to the pharmaceutical and medical device industries, emphasizing quality and compliance. The site details a range of capabilities, from serialisation to medical device manufacturing, and even boasts a 25-year history.

Financially, Pharmapac (U.K.) Limited has seen some interesting shifts. Accrued liabilities have decreased significantly, falling by 58%, while depreciation on plant and machinery has increased by 21%. Administrative expenses have also risen considerably, up 61%. Perhaps most notably, cash bank on hand has fallen by 43%, and bank borrowings have increased dramatically. Despite these challenges, turnover has grown by a substantial 73%, reaching £12 million. The company’s net assets have fallen by 26%, and a significant drop in trade debtors suggests potential issues with customer payments.

The company’s auditor is WHR Accountants Ltd. While the financial results show some volatility, the company’s long history and focus on a specialized manufacturing sector suggest resilience. The growth in turnover is a positive sign, but the decline in cash reserves warrants close monitoring.

Registered in England/Wales under the registration number 03201556, with a registered address at CH41 7EL, Bidston, Wirral, Unit 22, Valley Road Business Park.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.